News
Altos, led by industry stalwarts Hal Barron and Hans Bishop, brought Dorian Therapeutics into its fold this week, according ...
Juvenescence is out with a $76 million Series B-1, its first equity funding since before the Covid-19 pandemic.
Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...
The FDA's Oncologic Drugs Advisory Committee voted 8 to 1 against whether Genentech's pivotal trial is applicable to the US ...
The gene editing company CRISPR Therapeutics surprisingly struck a deal with China-based biotech Sirius Therapeutics to ...
FDA chief Marty Makary and new CBER Director Vinay Prasad said that future Covid-19 vaccine approvals will focus on adults ...
Under the program that was first announced by President Trump last week, the US would target prices based on benchmarks from ...
Calibrate names Rob Rebak as new CEO, replacing Rob MacNaughton, amid executive changes. CFO and Chief Clinical Officer also ...
Biotech execs express concerns over FDA changes, NIH cuts, and Trump's tariffs. Industry confidence low amid poor funding ...
Pfizer is dishing out $1.25 billion upfront and up to $4.8 billion in milestone payments to Shenyang-based 3SBio for the ...
A longevity startup called Retro Biosciences is working on personalized blood disorder therapies thanks to a partnership with ...
Regeneron has a long history with its gene-sequencing efforts, which likely provides some hints as to why the biotech saw the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results